Aethlon Medical (AEMD) Stock Price

Aethlon Medical Price

NASDAQ·CLOSED
5.27
​
Market closed

Revenue at Aethlon Medical has contracted by 7.5% per year over the past 11 years to 574,245.00 USD. Aethlon Medical's net margin stands at -2,094.9%, up from -2,697.9% several years earlier. Analysts set a median price target of 1.50 USD, implying 71.5% below the current price. Of 7 analysts, 0 rate the stock a buy — an overall Sell consensus.

Aethlon Medical stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Aethlon Medical business model & stock analysis

Aethlon Medical Inc, trading under the ticker AEMD, is a therapeutic technology company headquartered in San Diego, California. Listed on the market since March 9, 1994, the firm focuses on addressing global health and biodefense needs. The company operates through two primary segments: Aethlon, representing its therapeutic business activities, and ESI, which covers its diagnostic business activities. Its lead product is the Aethlon Hemopurifier, a device designed to selectively target the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. In the context of infectious viral pathogens, the Hemopurifier sheds glycoproteins for treatment. For oncology indications, it targets the removal of circulating exosomes released to promote cancer progression and seed metastasis spread. Additionally, through its subsidiary Exosome Sciences, Inc., the company is developing exosome-based product candidates intended to diagnose and monitor neurological disorders and cancer.

Frequently asked questions about Aethlon Medical

Analysts currently set an average price target of 1.50 USD for the Aethlon Medical stock (median: 1.50 USD), implying -71.5 % versus the latest price. The consensus is based on 7 analyst ratings.

7 analysts currently rate the Aethlon Medical stock: 0 recommend buying, 4 holding and 3 selling.

Converted at the current exchange rate, the Aethlon Medical share trades at 4.69 EUR (5.27 USD).

The Aethlon Medical share (AEMD) is listed on 5 stock exchanges, including: NASDAQ (AEMD), London (0A6R.L), Frankfurt (EJU.F), München (EJU.MU), Düsseldorf (EJU.DU).

The revenue cannot currently be calculated for Aethlon Medical.

The profit of Aethlon Medical is -7.15 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Aethlon Medical is currently -0.06. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Aethlon Medical stock.

The P/S cannot be calculated for Aethlon Medical currently.

The Eulerpool Quality Score for Aethlon Medical is 2/10.

The ISIN of Aethlon Medical is US00808Y6041. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Aethlon Medical is A2PTUU. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Aethlon Medical is AEMD. The ticker symbol is used to trade Aethlon Medical shares on the stock exchange.

Fair ValueTerminal
5.32 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Currency
USD
Initial public offering
Mar 9, 1994
ISIN
US00808Y6041
Cusip
00808Y307
Sedol
BKWD590
Market capitalization
52-Week Range
PEG
—
P/E ratio
P/Ee 2027
-0.45
P/Ee 2028
-4.56
P/Ee 2030
-11.81
P/Ee 2031
15.06
P/S
P/Se
—
EV/EBIT
0.53
P/B Ratio
0.17
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-136.92 %
Last updated Oct 17, 2026, 2:30 AM

Aethlon Medical Ticker

DÜSSELDORF · EJU.DUFRANKFURT · EJU.FLONDON · 0A6R.LMUNICH · EJU.MUNASDAQ · AEMD

All fundamentals and in-depth analysis of Aethlon Medical

Our stock analysis for Aethlon Medical stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Aethlon Medical. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.